ストックスクリーナーアプリを入手
8.91
1.71%
0.15
アフターアワーズ：
8.91
前日終値:
$8.76
開ける：
$8.52
24時間の取引高:
2.22M
Relative Volume:
1.66
時価総額：
$1.42B
収益：
$53.61M
当期純損益:
$-142.52M
株価収益率:
-8.027
EPS:
-1.11
ネットキャッシュフロー:
$-141.83M
1週間 パフォーマンス:
+9.59%
1か月 パフォーマンス:
+13.65%
6か月 パフォーマンス:
-17.58%
1年 パフォーマンス:
+59.96%
1日の値動き範囲:
$8.40
$8.975
1週間の範囲:
$7.80
$9.03
52週間の値動き範囲:
$5.04
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
WVE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
8.91 | 1.39B | 53.61M | -142.52M | -141.83M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-04 | 開始されました | Canaccord Genuity | Buy |
| 2025-07-28 | 開始されました | Oppenheimer | Outperform |
| 2025-07-16 | 開始されました | Citigroup | Buy |
| 2025-06-11 | 再開されました | Raymond James | Outperform |
| 2025-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 開始されました | Wedbush | Outperform |
| 2025-02-25 | 開始されました | Jefferies | Buy |
| 2024-10-16 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | 再開されました | JP Morgan | Overweight |
| 2024-09-19 | 開始されました | B. Riley Securities | Buy |
| 2024-09-09 | 開始されました | JP Morgan | Overweight |
| 2024-05-15 | 開始されました | Wells Fargo | Overweight |
| 2023-12-19 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 開始されました | Raymond James | Outperform |
| 2023-05-24 | ダウングレード | Jefferies | Buy → Hold |
| 2020-12-15 | 再開されました | H.C. Wainwright | Buy |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | 開始されました | Guggenheim | Buy |
| 2019-07-15 | 開始されました | Cowen | Market Perform |
| 2019-04-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-08-07 | 開始されました | Stifel | Buy |
| 2018-07-23 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-19 | 繰り返されました | Mizuho | Buy |
| 2017-02-15 | 開始されました | H.C. Wainwright | Buy |
| 2016-11-10 | 再開されました | Leerink Partners | Outperform |
| 2015-12-07 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-12-07 | 開始されました | Jefferies | Buy |
| 2015-12-07 | 開始されました | Leerink Partners | Outperform |
| 2015-12-07 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
すべてを表示
Wave Life Sciences Ltd (WVE) 最新ニュース
Wave Life Sciences Ltd. Recovery Linked to Earnings SurpriseJuly 2025 Highlights & High Accuracy Trade Signal Alerts - newsyoung.net
Wave Life Sciences director Henry sells $85k in shares - Investing.com
Wave Life Sciences Shareholders Approve Key Proposals - MSN
Will Weaker Sales and Deeper Losses Shift Wave Life Sciences' (WVE) Investment Narrative? - simplywall.st
Is Wave Life Sciences Ltd. the Top Chart Pick This WeekAI Based High Gain Watchlist Scanner Shared - beatles.ru
Wave Life Sciences is a new Buy at Canaccord Genuity on near-term catalysts - MSN
Wave Life Sciences Director Sells 1,127 Shares for $8.75 Each. - AInvest
Oppenheimer Initiates Wave Life Sciences(WVE.US) With Buy Rating, Announces Target Price $24 - 富途牛牛
CCORF Initiates Wave Life Sciences(WVE.US) With Buy Rating, Announces Target Price $19 - 富途牛牛
Wave Life Sciences Highlights RNA Platform Advancements - TipRanks
A Quick Look at Today's Ratings for Wave Life Sciences(WVE.US), With a Forecast Between $18 to $24 - 富途牛牛
Wave Life Sciences stock a new Buy at Canaccord Genuity (WVE) - Seeking Alpha
Wave Life Sciences stock initiated with Buy rating by Canaccord - Investing.com Australia
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Wave Life Sciences Ltd. shares rise 6.03% premarket after OraSure Technologies appoints new Chief Commercial Officer. - AInvest
Wave Life Sciences Ltd. (NASDAQ:WVE) Analysts Just Trimmed Their Revenue Forecasts By 13% - simplywall.st
Wave Life Sciences signals key Q3 and Q4 data catalysts as INHBE and AATD programs advance - MSN
When is Wave Life Sciences Ltd. stock expected to show significant growthSuperior stock growth - Jammu Links News
What analysts say about Wave Life Sciences Ltd. stockConsistent triple-digit returns - Jammu Links News
Earnings Update: Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported And Analysts Are Trimming Their Forecasts - 富途牛牛
How many analysts rate Wave Life Sciences Ltd. as a “Buy”Triple-digit wealth increases - Jammu Links News
What are analysts’ price targets for Wave Life Sciences Ltd. in the next 12 monthsUnlock powerful trading strategies for gains - Jammu Links News
What is Wave Life Sciences Ltd. company’s growth strategyDiscover undervalued stocks ready to soar - Jammu Links News
Is Wave Life Sciences Ltd. a growth stock or a value stockExceptional profit potential - Jammu Links News
What are the latest earnings results for Wave Life Sciences Ltd.Capitalize on emerging market sectors - Jammu Links News
How does Wave Life Sciences Ltd. compare to its industry peersBuild a portfolio that withstands market volatility - Jammu Links News
Insights Into WAVE Life Sciences's Upcoming Earnings - 富途牛牛
How strong is Wave Life Sciences Ltd. company’s balance sheetSmart Portfolio Outlook For Consistent Profits - Jammu Links News
Why is Wave Life Sciences Ltd. stock attracting strong analyst attentionPost Market Updates For Consistent Profits - Jammu Links News
Wave Life Sciences Ltd. shares rise 2.72% intraday after TELUS CORPORATION's ESG initiatives and new product focus. - AInvest
WAVE Life Sciences Reports Q2 2025 Earnings: RNA Editing Progress Amid Revenue Decline and Strong Cash Position - AInvest
Wave Life Sciences Second Quarter 2025 Earnings: Misses Expectations - simplywall.st
Wave Life Sciences Ltd. (NASDAQ:WVE) Q2 2025 Earnings Call Transcript - Insider Monkey
Need To Know: The Consensus Just Cut Its Wave Life Sciences Ltd. (NASDAQ:WVE) Estimates For 2025 - Yahoo Finance
Wave Life Sciences Earnings Call: Clinical Advances Amid Financial Challenges - TipRanks
Is it the right time to buy Wave Life Sciences Ltd. stockStock Strategy Recommendation From AI Tools - jammulinksnews.com
Wave (WVE) Q2 Revenue Drops 56% - AOL.com
Wave Life Sciences Ltd.'s (NASDAQ:WVE) 26% Share Price Surge Not Quite Adding Up - simplywall.st
What catalysts could drive Wave Life Sciences Ltd. stock higher in 2025Expert Picks Tips For Beginners - Jammu Links News
Wave Life Sciences: Q2 Earnings Snapshot - Huron Daily Tribune
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates - sharewise.com
WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Call Highlights: Progress in RNA Editing Amid ... - Yahoo Finance
Wave (WVE) Q2 Revenue Drops 56% - The Motley Fool
Wave Life Sciences Advances RNA Medicine Pipeline - TipRanks
WAVE Life Sciences Q2 2025 Earnings Call Transcript - MarketBeat
Wave Life Sciences 2025 Q2 Earnings Revenue Drops 56%, Net Loss Widens - AInvest
Top Risks to Consider Before Buying Wave Life Sciences Ltd. StockOversold Recovery Opportunity Stocks Attract Buyers - metal.it
Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Wave Life Sciences Ltd (WVE) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
1.56%
大文字化:
|
ボリューム (24 時間):